{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:52:41Z","timestamp":1790686361761,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T00:00:00Z","timestamp":1641340800000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ejvesreports.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EJVES Vascular Forum"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/j.ejvsvf.2022.01.003","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T06:20:49Z","timestamp":1641795649000},"page":"58-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Five Year Outcomes in Patients with End Stage Renal Disease Who Received a Bioengineered Human Acellular Vessel for Dialysis Access"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3012-2215","authenticated-orcid":false,"given":"Tomasz","family":"Jakimowicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislaw","family":"Przywara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Turek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8192-566X","authenticated-orcid":false,"given":"Alison","family":"Pilgrim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Macech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Zapotoczny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Zubilewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey H.","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Niklason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejvsvf.2022.01.003_bib1","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jvs.2016.01.053","article-title":"Outcomes of vascular access for hemodialysis: a systematic review and meta-analysis","volume":"64","author":"Almasri","year":"2016","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvsvf.2022.01.003_bib2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/112972981001100213","article-title":"Infection of hemodialysis arteriovenous grafts","volume":"11","author":"Akoh","year":"2010","journal-title":"J\u00a0Vasc Access"},{"key":"10.1016\/j.ejvsvf.2022.01.003_bib3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jamcollsurg.2005.03.040","article-title":"Multicenter evaluation of the bovine mesenteric vein bioprostheses for hemodialysis access in patients with an earlier failed prosthetic graft","volume":"201","author":"Katzman","year":"2005","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.ejvsvf.2022.01.003_bib4","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.jvs.2018.01.049","article-title":"Utilization, patency, and complications associated with vascular access for hemodialysis in the United States","volume":"68","author":"Arhuidese","year":"2018","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvsvf.2022.01.003_bib5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1073-4449(12)80044-6","article-title":"The treatment of vascular access graft dysfunction: a nephrologist's view and experience","volume":"1","author":"Beathard","year":"1994","journal-title":"Adv Ren Replace Ther"},{"key":"10.1016\/j.ejvsvf.2022.01.003_bib6","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa0805840","article-title":"Effect of dipyridamole plus aspirin on hemodialysis graft patency","volume":"360","author":"Dixon","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"Suppl. 2","key":"10.1016\/j.ejvsvf.2022.01.003_bib7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.5301\/jva.5000723","article-title":"Comparison of post-creation procedures and costs between surgical and an endovascular approach to arteriovenous fistula creation","volume":"18","author":"Yang","year":"2017","journal-title":"J\u00a0Vasc Access"},{"key":"10.1016\/j.ejvsvf.2022.01.003_bib8","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1681\/ASN.2012070643","article-title":"Associations between hemodialysis access type and clinical outcomes: a systematic review","volume":"24","author":"Ravani","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ejvsvf.2022.01.003_bib9","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0272-6386(04)01078-9","article-title":"Dialysis catheter-related bacteremia: treatment and prophylaxis","volume":"44","author":"Allon","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ejvsvf.2022.01.003_bib10","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1089\/ten.teb.2015.0100","article-title":"The tissue-engineered vascular graft-past, present, and future","volume":"22","author":"Pashneh-Tala","year":"2016","journal-title":"Tissue Eng Part B Rev"},{"key":"10.1016\/j.ejvsvf.2022.01.003_bib11","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/S0140-6736(09)60248-8","article-title":"Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study","volume":"373","author":"McAllister","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ejvsvf.2022.01.003_bib12","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1046\/j.1525-1594.2001.06716.x","article-title":"A\u00a0hybrid compliant vascular graft seeded with microvascular endothelial cells extracted from human omentum","volume":"25","author":"Salacinski","year":"2001","journal-title":"Artif Organs"},{"key":"10.1016\/j.ejvsvf.2022.01.003_bib13","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/S0140-6736(16)00557-2","article-title":"Bioengineered human acellular vessels for dialysis access in patients with end-stage renal disease: two phase 2 single-arm trials","volume":"387","author":"Lawson","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ejvsvf.2022.01.003_bib14","doi-asserted-by":"crossref","first-page":"68ra9","DOI":"10.1126\/scitranslmed.3001426","article-title":"Readily available tissue-engineered vascular grafts","volume":"3","author":"Dahl","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ejvsvf.2022.01.003_bib15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jss.2017.08.035","article-title":"Susceptibility of ePTFE vascular grafts and bioengineered human acellular vessels to infection","volume":"221","author":"Kirkton","year":"2018","journal-title":"J\u00a0Surg Res"},{"key":"10.1016\/j.ejvsvf.2022.01.003_bib16","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1126\/science.284.5413.489","article-title":"Functional arteries grown in\u00a0vitro","volume":"284","author":"Niklason","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.ejvsvf.2022.01.003_bib17","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3727\/000000003108747136","article-title":"Decellularized native and engineered arterial scaffolds for transplantation","volume":"12","author":"Dahl","year":"2003","journal-title":"Cell Transplant"},{"key":"10.1016\/j.ejvsvf.2022.01.003_bib18","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/S0140-6736(05)66735-9","article-title":"Blood vessels engineered from human cells","volume":"365","author":"Poh","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ejvsvf.2022.01.003_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau6934","article-title":"Bioengineered human acellular vessels recellularize and evolve into living blood vessels after human implantation","volume":"11","author":"Kirkton","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ejvsvf.2022.01.003_bib20","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.jvs.2019.11.056","article-title":"Arterial reconstruction with human bioengineered acellular blood vessels in patients with peripheral arterial disease","volume":"72","author":"Gutowski","year":"2020","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvsvf.2022.01.003_bib21","series-title":"USRDS Annual Data Report: epidemiology of kidney disease in the United States","year":"2018"}],"container-title":["EJVES Vascular Forum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666688X2200003X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666688X2200003X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T04:06:02Z","timestamp":1763006762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666688X2200003X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":21,"alternative-id":["S2666688X2200003X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejvsvf.2022.01.003","relation":{},"ISSN":["2666-688X"],"issn-type":[{"value":"2666-688X","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Five Year Outcomes in Patients with End Stage Renal Disease Who Received a Bioengineered Human Acellular Vessel for Dialysis Access","name":"articletitle","label":"Article Title"},{"value":"EJVES Vascular Forum","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejvsvf.2022.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd on behalf of European Society for Vascular Surgery.","name":"copyright","label":"Copyright"}]}}